Comprehensive management of immune-related adverse events: predictive strategies, mechanistic insights, and therapeutic approaches
{{output}}
Immune checkpoint inhibitors (ICIs) have been game changer in cancer therapy but can trigger diverse immune-related adverse events (irAEs) that impact multiple organs. This review offers a unified perspective on irAE risk assessment, underlying mechanisms, and... ...
